Director/PDMR Shareholding

RNS Number : 6308H

AstraZeneca PLC

24 February 2010

 



Transaction by Persons Discharging Managerial Responsibilities

Disclosure Rule DTR 3.1.4

We hereby inform you that on 23 February 2010, the interest of David Brennan, a Director of the Company, in AstraZeneca PLC Ordinary Shares of $0.25 each, changed as detailed below.  The change in interest relates to the vesting of a previously announced award made in February 2007 under the AstraZeneca Deferred Bonus Plan whereby Mr Brennan has now become beneficially entitled to the shares.  Sufficient shares were withheld to cover certain tax obligations arising on the vesting.

Name of Director	Number of shares vested	Number of shares withheld	Net number of shares	Market price on vesting
David R Brennan	12,014	4,926	7,088	2810p

Mr Brennan has interests in both the Ordinary Shares and the American Depositary Shares (ADSs) of AstraZeneca PLC.  One ADS equals one Ordinary Share.

As a result of this transaction, Mr Brennan now has an interest in 495,995 Ordinary Shares and 78,007 AstraZeneca ADSs, which together represent approximately 0.04% of the Company's issued ordinary capital.

A C N Kemp

Company Secretary

24 February 2010

 

END

 

 

RDSUSRNRRKAUUAR